rs367826825
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_032119.4(ADGRV1):c.1505C>A(p.Ala502Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A502V) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADGRV1 | NM_032119.4 | c.1505C>A | p.Ala502Glu | missense_variant | Exon 8 of 90 | ENST00000405460.9 | NP_115495.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | ENST00000405460.9 | c.1505C>A | p.Ala502Glu | missense_variant | Exon 8 of 90 | 1 | NM_032119.4 | ENSP00000384582.2 | ||
| ADGRV1 | ENST00000504142.2 | n.271C>A | non_coding_transcript_exon_variant | Exon 2 of 14 | 5 | |||||
| ADGRV1 | ENST00000640083.1 | n.1210C>A | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 | |||||
| ADGRV1 | ENST00000640109.1 | n.1601C>A | non_coding_transcript_exon_variant | Exon 8 of 9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461256Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726868 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1505C>A (p.A502E) alteration is located in exon 8 (coding exon 8) of the ADGRV1 gene. This alteration results from a C to A substitution at nucleotide position 1505, causing the alanine (A) at amino acid position 502 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at